Dapagliflozin Improves MASH Without worsening liver fibrosis in new Trial Dr. Shravani Dali12 Jun 2025 11:00 AM ISTResearchers have found in a randomized trial in China that dapagliflozin, an SGLT2 inhibitor, improved metabolic dysfunction-associated...
Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad Ruchika Sharma6 Jun 2025 5:30 PM ISTTelangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...
Diabetes drug shows benefits for patients with liver disease: Study Dr. Kamal Kant Kohli5 Jun 2025 5:30 AM ISTThe sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients...
CDSCO Panel Approves BE Study for Alkem's Dapagliflozin, Pioglitazone, Metformin FDC, Seeks Revised Phase III Plan Dr. Divya Colin2 Jun 2025 1:51 PM ISTNew Delhi: Alkem Laboratories has received approval from the Subject Expert Committee (SEC) under the Central Drug Standard Control Organisation...
Justify Sample Size Hike in FDC Trial of Zibotentan-Dapagliflozin, CDSCO Panel Tells AstraZeneca Dr. Divya Colin31 May 2025 6:04 PM ISTNew Delhi: Reviewing the amendment protocol of the AstraZeneca's fixed dose combination (FDC) Zibotentan plus Dapagliflozin, the Subject Expert...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Dapagliflozin Sitagliptin-Preferred SGLT2i-DPP4i FDC in Indian Clinical Practice Dr. Saptarshi Bhattacharya7 April 2025 11:34 AM ISTType 2 diabetes mellitus (T2DM) is a major public health challenge in India, with an estimated 101 million individuals affected and 39.4 million...
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIA Farhat Nasim24 Feb 2025 5:12 PM ISTVonoprazan-based GI drugs led new launches, generating Rs 187 crore from 404 brands.
